Dopamine Reuptake Inhibitors of Cocaine Abuse - 1

Yale University

Status and phase: Terminated; Phase 1

Conditions: Cocaine-Related Disorders

Treatments: Drug: Bupropion

Study type: Interventional

Funder types: Other; Other U.S. Federal agency; NIH

Identifiers

NCT00000276

P50-09250-1

P50DA009250 (U.S. NIH Grant/Contract)

NIDA-09250-1

Details and patient eligibility

About

The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.

Sex: All

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria